The European Laboratory Analysis & Innovation Group (ELRIG) UK in the present day introduced the keynote audio system for Drug Discovery 2023, happening on the ACC in Liverpool from 18–19 October. Prof Janet Hemingway CBE, FRS, Founding Director of An infection Innovation Consortium (iiCON), and Dr Dave Powell, Chief Scientific Officer (CSO) of LifeArc will lead this yr’s occasion focussing on numerous pondering and new views.
The group’s free-to-attend, flagship convention will cowl a variety of themes from ‘omics, and customized medication to chemistry; all centered on bringing new therapies from the lab to the affected person.
Janet Hemingway is Professor of Tropical Medication on the Liverpool Faculty of Tropical Medication (LSTM) and the Founding Director of iiCON, a collaborative £230 million programme bringing collectively educational, business and medical companions to assist remodel the invention and provide of anti-infectives and speed up their journey to market. She is a senior technical advisor on Uncared for Tropical Ailments for the Invoice and Melinda Gates Basis and has been PI on tasks in extra of £370 million. Prof Hemingway was Director of LSTM from 2001 to 2019 and she or he was awarded a CBE for companies to the Management of Tropical Illness Vectors in 2012.
Dave Powell joined LifeArc as CSO in 2022 as the following step in his 25 years in R&D. Previous to this he led the preclinical drug discovery and the part lll antibiotic analysis programme at Summit Therapeutics. Dr Powell started his life sciences profession at SmithKline Beecham (now GSK), gaining deep platform and undertaking expertise throughout quite a few therapeutic areas, together with neurosciences, oncology, and infectious illness. He additionally helped to begin after which led the collaboration between GSK and the Francis Crick Institute in London.
Drug Discovery 2023 will embody displays from leaders of their fields, a commerce present and exhibition, a poster competitors, tech theatres focussed on robotics and automation, and sustainability practices, a number of networking alternatives and a studying zone for early profession professionals.
The convention will run 4 parallel periods every day focussed on: mobile applied sciences for drug discovery, reworking most cancers drug discovery by numerous pondering and improvements, delving into the range of chemistry, driving molecules from idea to clinic, augmenting R&D with AI, biopharmaceutical discovery, translating concepts into therapies, hit identification and screening, and chemistry enabling drug discovery from begin to clinic.
ELRIG is devoted to delivering nice scientific content material with range and inclusivity inbuilt, and the calibre of talks at this yr’s occasion are testomony to that. The keynote audio system are such influential and extremely revered scientists of their respective fields. We’re delighted to have them lead the scientific programme at Drug Discovery 2023 and help us in driving collaboration throughout the scientific neighborhood as we proceed to develop our numerous community.”
Sanj Kumar, CEO, ELRIG UK.
It’s an honour to be presenting at this yr’s Drug Discovery occasion in Liverpool. I look ahead to connecting with thought leaders, sharing insights, and gaining new views on key areas of significance within the subject and future instructions for novel therapeutics.”
Prof Janet Hemingway, Founding Director, iiCON.
I’m captivated with discovery innovation but additionally about how we are able to practice and put together the following era of drug discovery scientists. So, I’m proud to be presenting at ELRIG’s flagship occasion this yr the place new concepts and know-how are at all times to the fore, however importantly ELRIG Drug Discovery is a extremely approachable convention for our youthful colleagues as effectively.”
Dr Dave Powell, CSO, LifeArc.
For a full itemizing of audio system and periods, to register or e book an exhibition stand, please go to: https://www.elrig.org/portfolio/drug-discovery-2023/